Oral Semaglutide 50mg Shows Significant Weight Loss for Overweight and Obesity
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
Background
Obesity and overweight are global health challenges requiring effective and accessible treatment strategies. While semaglutide tablets are already approved at lower doses for type 2 diabetes, their efficacy and safety at a higher oral dose specifically for weight loss in individuals without diabetes remained less explored. This pivotal study, OASIS 1, aimed to evaluate the effectiveness of a higher-dose oral semaglutide formulation for comprehensive weight management in people living with overweight or obesity.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
